• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤学中的逐步升级、维持和放弃:一种新的研究设计,以确定患者的个体价值观如何影响妇科肿瘤和结直肠癌病例中新型治疗概念的风险和益处评估:一项研究方案

Escalation, maintenance and abstention in oncology a new study design to identify how individual values of patients impact on the assessment of risks and benefits of novel therapeutic concepts in cases of gynaecological tumors and colorectal cancer: a study protocol.

作者信息

Theis Susanne, Senyigit Jülide, Büchler Britta, Kolck Gesa, Moehler Markus, Hasenburg Annette, Paul Norbert

机构信息

Department of Obstetrics and Gynegology, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany.

Institute of History, Philosophy, and Ethics of Medicine, Johannes Gutenberg University Medical Center Mainz, Mainz, Germany.

出版信息

Front Oncol. 2025 Jul 8;15:1588721. doi: 10.3389/fonc.2025.1588721. eCollection 2025.

DOI:10.3389/fonc.2025.1588721
PMID:40708933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12287738/
Abstract

Being diagnosed with cancer is a life-altering event that profoundly reshapes an indivdual's biography, especially in terms of temporality and physicality. Modern treatment approaches, such as maintenance therapy or therapeutic abstinence, often conflict with patients' desire for a radical fight against the disease. Decision-making about therapeutic goals is shaped by the tension between medical-scientific expertise and personal values and experiences, making it particularly challenging to align diverse preferences and norms. This study aims to analyse values in the context of the challenging human experience of cancer. We hypothesise that conventional quantitative measures, including patient-reported outcome measures (PROMs) may be insufficient to fully capture patients' perspective on therapeutic success. To address this, we will conduct semi-structured interviews with individuals diagnosed with gynecological or colorectal cancer. Using a mixed methods approach, we aim to identify patients' values, treatment goals, and expectations. The study's key outcomes include: 1) an ethical analysis of values in the context of cancer experiences 2) a reconstruction of values that shape individual treatment goals and expectations and 3) a comparison between ethical concepts of successful life, patients' situational values, and evidence-based medical preferences. Building on these insights, the study pursues three secondary objectives: 1) developing a strategy for patient-centred adaptation of clinical evaluations of treatment approaches, including escalation, maintenance and abstinence, 2) designing a well-defined clinical framework for therapeutic goal setting, and 3) integrating this framework into medical education, addressing clinical, oncological, ethical and communication competencies.

摘要

被诊断出患有癌症是一件改变人生的大事,它会深刻重塑一个人的人生轨迹,尤其是在时间性和身体方面。现代治疗方法,如维持治疗或治疗性节制,往往与患者彻底对抗疾病的愿望相冲突。关于治疗目标的决策受到医学科学专业知识与个人价值观和经历之间张力的影响,这使得协调不同的偏好和规范极具挑战性。本研究旨在分析癌症这一具有挑战性的人类经历背景下的价值观。我们假设,包括患者报告结局测量(PROMs)在内的传统定量测量方法可能不足以充分捕捉患者对治疗成功的看法。为解决这一问题,我们将对被诊断患有妇科或结直肠癌的个体进行半结构化访谈。采用混合方法,我们旨在确定患者的价值观、治疗目标和期望。该研究的主要成果包括:1)对癌症经历背景下的价值观进行伦理分析;2)重构塑造个体治疗目标和期望的价值观;3)比较成功人生的伦理概念、患者的情境价值观和循证医学偏好。基于这些见解,该研究追求三个次要目标:1)制定以患者为中心的治疗方法临床评估调整策略,包括强化、维持和节制;2)设计一个明确的治疗目标设定临床框架;3)将该框架纳入医学教育,涉及临床、肿瘤学、伦理和沟通能力。

相似文献

1
Escalation, maintenance and abstention in oncology a new study design to identify how individual values of patients impact on the assessment of risks and benefits of novel therapeutic concepts in cases of gynaecological tumors and colorectal cancer: a study protocol.肿瘤学中的逐步升级、维持和放弃:一种新的研究设计,以确定患者的个体价值观如何影响妇科肿瘤和结直肠癌病例中新型治疗概念的风险和益处评估:一项研究方案
Front Oncol. 2025 Jul 8;15:1588721. doi: 10.3389/fonc.2025.1588721. eCollection 2025.
2
The Lived Experience of Autistic Adults in Employment: A Systematic Search and Synthesis.成年自闭症患者的就业生活经历:系统检索与综述
Autism Adulthood. 2024 Dec 2;6(4):495-509. doi: 10.1089/aut.2022.0114. eCollection 2024 Dec.
3
Sexual Harassment and Prevention Training性骚扰与预防培训
4
"In a State of Flow": A Qualitative Examination of Autistic Adults' Phenomenological Experiences of Task Immersion.“心流状态”:对自闭症成年人任务沉浸现象学体验的质性研究
Autism Adulthood. 2024 Sep 16;6(3):362-373. doi: 10.1089/aut.2023.0032. eCollection 2024 Sep.
5
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
6
Accreditation through the eyes of nurse managers: an infinite staircase or a phenomenon that evaporates like water.护士长眼中的认证:是无尽的阶梯还是如流水般消逝的现象。
J Health Organ Manag. 2025 Jun 30. doi: 10.1108/JHOM-01-2025-0029.
7
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理:一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.
8
Can We Enhance Shared Decision-making for Periacetabular Osteotomy Surgery? A Qualitative Study of Patient Experiences.我们能否加强髋臼周围截骨术的共同决策?一项关于患者体验的定性研究。
Clin Orthop Relat Res. 2025 Jan 1;483(1):120-136. doi: 10.1097/CORR.0000000000003198. Epub 2024 Jul 23.
9
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
10
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.

本文引用的文献

1
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial.结直肠癌的共识分子亚群(CMS)和 FOLFIRI 联合西妥昔单抗或贝伐珠单抗一线治疗在 FIRE3(AIO KRK-0306)试验中的疗效。
Ann Oncol. 2019 Nov 1;30(11):1796-1803. doi: 10.1093/annonc/mdz387.
2
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164.帕博利珠单抗治疗难治性、微卫星不稳定/错配修复缺陷型转移性结直肠癌的 II 期开放标签研究:KEYNOTE-164。
J Clin Oncol. 2020 Jan 1;38(1):11-19. doi: 10.1200/JCO.19.02107. Epub 2019 Nov 14.
3
Adaptive mutability of colorectal cancers in response to targeted therapies.结直肠癌对靶向治疗的适应性突变。
Science. 2019 Dec 20;366(6472):1473-1480. doi: 10.1126/science.aav4474. Epub 2019 Nov 7.
4
Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases.扩展分子谱分析可改善结直肠癌肝转移切除术后的分层和生存预测。
Ann Surg. 2019 Nov;270(5):799-805. doi: 10.1097/SLA.0000000000003527.
5
FOLFOXIRI Plus Panitumumab As First-Line Treatment of Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109).FOLFOXIRI 联合帕尼单抗作为野生型转移性结直肠癌一线治疗:随机、开放标签、II 期 VOLFI 研究(AIO KRK0109)
J Clin Oncol. 2019 Dec 10;37(35):3401-3411. doi: 10.1200/JCO.19.01340. Epub 2019 Oct 14.
6
Encorafenib, Binimetinib, and Cetuximab in V600E-Mutated Colorectal Cancer.encorafenib、binimetinib 和西妥昔单抗治疗 V600E 突变型结直肠癌。
N Engl J Med. 2019 Oct 24;381(17):1632-1643. doi: 10.1056/NEJMoa1908075. Epub 2019 Sep 30.
7
Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials.基于帕尼单抗的奥沙利铂停药后维持治疗转移性结直肠癌:两项随机试验的回顾性分析。
Int J Cancer. 2019 Jul 15;145(2):576-585. doi: 10.1002/ijc.32110. Epub 2019 Jan 24.
8
Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.贝伐珠单抗联合卡培他滨维持治疗转移性结直肠癌的成本效果分析
JAMA Oncol. 2019 Feb 1;5(2):236-242. doi: 10.1001/jamaoncol.2018.5070.
9
Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonists.胃肠肿瘤的免疫肿瘤学:PD-1/PD-L1 拮抗剂的临床证据和新试验。
Crit Rev Oncol Hematol. 2018 Oct;130:13-26. doi: 10.1016/j.critrevonc.2018.07.001. Epub 2018 Jul 11.
10
Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial.西妥昔单抗联合改良 FOLFOXIRI 方案治疗后贝伐珠单抗或西妥昔单抗维持治疗 RAS 和 BRAF 野生型转移性结直肠癌的疗效和安全性:一项随机 2 期临床试验。
JAMA Oncol. 2018 Apr 1;4(4):529-536. doi: 10.1001/jamaoncol.2017.5314.